These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34695841)

  • 1. Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial.
    Kim YB; Byun HK; Kim DY; Ahn SJ; Lee HS; Park W; Kim SS; Kim JH; Lee KC; Lee IJ; Kim WT; Shin HS; Kim K; Shin KH; Nam CM; Suh CO
    JAMA Oncol; 2022 Jan; 8(1):96-105. PubMed ID: 34695841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.
    Zhao XR; Fang H; Tang Y; Hu ZH; Jing H; Liang L; Yan XN; Song YW; Jin J; Liu YP; Chen B; Tang Y; Qi SN; Li N; Lu NN; Men K; Hu C; Zhang YH; Li YX; Wang SL
    BMC Cancer; 2021 Nov; 21(1):1185. PubMed ID: 34742270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting.
    Wang X; Luo J; Jin K; Chen X; Zhang L; Meng J; Zhang X; Zhang Z; Shao Z; Bazan JG; Guo X; Yang Z; Yu X
    Breast Cancer; 2020 Mar; 27(2):252-260. PubMed ID: 31696449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internal mammary node irradiation in node-positive breast cancer treated with mastectomy and taxane-based chemotherapy.
    Cho WK; Chang JS; Park SG; Kim N; Choi DH; Kim H; Kim YB; Park W; Suh CO
    Breast; 2021 Oct; 59():37-43. PubMed ID: 34126377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up.
    Chang JS; Park W; Kim YB; Lee IJ; Keum KC; Lee CG; Choi DH; Suh CO; Huh SJ
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):867-72. PubMed ID: 23747215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer.
    Thorsen LB; Offersen BV; Danø H; Berg M; Jensen I; Pedersen AN; Zimmermann SJ; Brodersen HJ; Overgaard M; Overgaard J
    J Clin Oncol; 2016 Feb; 34(4):314-20. PubMed ID: 26598752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast Cancer: A Meta-Analysis.
    Shaikh PM; Mulherkar R; Khasawneh MT; Clump D; Hazard-Jenkins H; Hafez M; Vargo JA
    Am J Clin Oncol; 2024 Feb; 47(2):81-87. PubMed ID: 37916961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal Mammary Node Irradiation (IMNI) Improves Survival Outcome for Patients With Clinical Stage II-III Breast Cancer After Preoperative Systemic Therapy.
    Luo J; Jin K; Chen X; Wang X; Yang Z; Zhang L; Mei X; Ma J; Zhang X; Zhou Z; Wang X; Jiang Y; Shao Z; Zhang Z; Guo X; Yu X
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):895-904. PubMed ID: 30439485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer.
    Qi WX; Cao L; Zheng S; Xu C; Cai R; Xu H; Cai G; Chen J
    BMC Cancer; 2022 Dec; 22(1):1356. PubMed ID: 36575421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.
    Poortmans PM; Weltens C; Fortpied C; Kirkove C; Peignaux-Casasnovas K; Budach V; van der Leij F; Vonk E; Weidner N; Rivera S; van Tienhoven G; Fourquet A; Noel G; Valli M; Guckenberger M; Koiter E; Racadot S; Abdah-Bortnyak R; Van Limbergen EF; Engelen A; De Brouwer P; Struikmans H; Bartelink H;
    Lancet Oncol; 2020 Dec; 21(12):1602-1610. PubMed ID: 33152277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy?
    Kim KH; Noh JM; Kim YB; Chang JS; Keum KC; Huh SJ; Choi DH; Park W; Suh CO
    Breast Cancer Res Treat; 2015 Aug; 152(3):589-99. PubMed ID: 26202053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study.
    Thorsen LBJ; Overgaard J; Matthiessen LW; Berg M; Stenbygaard L; Pedersen AN; Nielsen MH; Overgaard M; Offersen BV;
    J Clin Oncol; 2022 Dec; 40(36):4198-4206. PubMed ID: 35394824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.
    Poortmans PM; Collette S; Kirkove C; Van Limbergen E; Budach V; Struikmans H; Collette L; Fourquet A; Maingon P; Valli M; De Winter K; Marnitz S; Barillot I; Scandolaro L; Vonk E; Rodenhuis C; Marsiglia H; Weidner N; van Tienhoven G; Glanzmann C; Kuten A; Arriagada R; Bartelink H; Van den Bogaert W;
    N Engl J Med; 2015 Jul; 373(4):317-27. PubMed ID: 26200978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center.
    Misra S; Lee G; Maganti M; Koch CA
    Breast Cancer Res Treat; 2020 Jul; 182(2):367-379. PubMed ID: 32474745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of the Addition of Internal Mammary Irradiation to Standard Adjuvant Radiation in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis.
    Korzets Y; Levitas D; Grubstein A; Corn BW; Amir E; Goldvaser H
    Curr Oncol; 2022 Sep; 29(9):6657-6673. PubMed ID: 36135092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
    JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can internal mammary lymph nodes irradiation bring survival benefits for breast cancer patients? A systematic review and meta-analysis of 12,705 patients in 12 studies.
    Jia S; Liu Z; Zhang J; Zhao C; Zhu L; Kong J; Han H; Shang Y; Shen D; Duan X
    Radiat Oncol; 2021 Feb; 16(1):42. PubMed ID: 33622345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.
    Coombes RC; Tovey H; Kilburn L; Mansi J; Palmieri C; Bartlett J; Hicks J; Makris A; Evans A; Loibl S; Denkert C; Murray E; Grieve R; Coleman R; Borley A; Schmidt M; Rautenberg B; Kunze CA; Rhein U; Mehta K; Mousa K; Dibble T; Lu XL; von Minckwitz G; Bliss JM;
    JAMA Oncol; 2021 Sep; 7(9):1291-1301. PubMed ID: 34264305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14).
    Kim K; Jeong Y; Shin KH; Kim JH; Ahn SD; Kim SS; Suh CO; Kim YB; Choi DH; Park W; Cha J; Chun M; Lee DS; Lee SY; Kim JH; Park HJ; Jung W
    Cancer Res Treat; 2019 Oct; 51(4):1500-1508. PubMed ID: 30913866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.